Delayed Platelet Engraftment and Ongoing Pulmonary Infection Following Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation: A Case Study

Overview

This case study reports a 52-year-old woman who experienced delayed platelet engraftment and severe pulmonary infections following haploidentical allogeneic hematopoietic stem cell transplantation (HSCT). Despite achieving neutrophil engraftment, she faced significant complications, including invasive fungal pneumonia and septic shock, ultimately leading to her death six months post-transplant.

Background

Incorporate statistics or references to support the claims regarding PGF and infection interplay.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

• Patient developed Rhizopus microsporus infection on day +1 post-transplant.
• Neutrophil engraftment occurred by day +13, while platelet engraftment was delayed until day +40.
• Subsequent infections included Pseudomonas aeruginosa septic shock and multidrug-resistant Klebsiella pneumoniae superinfection.
• Thrombopoietin receptor agonists showed minimal response in the context of active infection.
• The patient died six months post-transplant, highlighting the need for effective infection control prior to PGF-directed therapy.

Clinical Implications

This case underscores the importance of early infection management in patients undergoing HSCT to prevent complications like delayed platelet engraftment. Clinicians should consider the potential for infections to hinder recovery and the limited efficacy of thrombopoietin receptor agonists during active infections.

Conclusion

Reiterate the importance of proactive measures and suggest potential areas for future research.

References

1. Bone Marrow Transplantation, 2020 -- 46th Annual Conference of the European Society for Blood and Marrow Transplantation: Physicians' Poster Presentations
2. Bone Marrow Transplantation, 2015 -- Advancements in Haploidentical Stem Cell Transplantation Techniques
3. Bone Marrow Transplantation, 2024 -- 50th Annual Conference of the European Society for Blood and Marrow Transplantation: Physician Presentations
4. Blood Cancer Journal, 2021 -- Successful Allogeneic Hematopoietic Stem Cell Transplantation Achieved with Morphologic Leukemia-Free Status in Acute Myeloid Leukemia
5. Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation - PubMed
6. Efficacy of therapeutic strategies on thrombocytopenia after hematopoietic stem cell transplantation—an evidence-based meta-analysis, 2025
7. Use of isavuconazole in mucormycosis: a systematic review - PubMed
8. Harmonizing definitions for hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the EBMT, ASTCT, CIBMTR, and APBMT - PubMed
9. Efficacy of therapeutic strategies on thrombocytopenia after hematopoietic stem cell transplantation—an evidence-based meta-analysis - Wenxi Hua, Yunyi Chen, Jiaqian Qi, Xiaofei Song, Meng Zhou, Yue Han, 2025
10. Use of isavuconazole in mucormycosis: a systematic review - PubMed